Curcumin Supplementation and Inflammatory Biomarkers A Systematic Review
DOI:
https://doi.org/10.37899/mjdh.v3i3.416Keywords:
Antioxidant Therapy, Chronic Inflammation, C-Reactive Protein, Curcumin Supplementation, Inflammatory Biomarkers, Randomized Controlled Trials, Systematic ReviewAbstract
Chronic inflammation is a key contributor to the development and progression of numerous non-communicable diseases, creating increasing interest in safe and effective nutritional interventions. This systematic review aimed to synthesize contemporary evidence regarding the effects of curcumin supplementation on inflammatory biomarkers in human clinical studies. A systematic literature search was conducted in major scientific databases, and eligible randomized controlled trials were selected according to predefined inclusion and exclusion criteria. The extracted evidence was synthesized narratively with emphasis on major inflammatory biomarkers, intervention characteristics, and methodological quality. The available evidence indicates that curcumin supplementation is associated with favorable modulation of inflammatory biomarkers, particularly C-reactive protein, high-sensitivity C-reactive protein, interleukin-6, and tumor necrosis factor alpha, although the magnitude of these effects varies according to disease characteristics, dosage, treatment duration, and formulation. These findings contribute to the growing body of knowledge supporting curcumin as a complementary nutritional intervention for chronic inflammatory conditions and provide practical considerations for clinicians, nutrition researchers, and healthcare professionals. Further high-quality randomized controlled trials employing standardized intervention protocols are required to strengthen the evidence base and guide future clinical recommendations.
References
Ali, S., Zehra, A., Khalid, M. U., Hassan, M., & Shah, S. I. A. (2023). Role of C-reactive protein in disease progression, diagnosis and management. Discoveries, 11(4), e179. https://doi.org/10.15190/d.2023.18
Al-Shuhaib, M. B. S. (2026). Protocatechuic acid as the pleiotropic bioactive agent: therapeutic potentials and mechanistic insights. Phytochemistry Reviews, 1-79. https://doi.org/10.1007/s11101-026-10269-z
Antar, S. A., Mahmoud, A. M., Abdo, W., Gad, C., & Al-Karmalawy, A. A. (2023). A comprehensive overview of organ inflammatory responses: Genesis, possible mechanisms, and mediators of inflammation. Pharmaceutical Sciences, 29(4), 397-416. https://doi.org/10.34172/PS.2023.9
Banait, T., Wanjari, A., Danade, V., Banait, S., & Jain, J. (2022). Role of high-sensitivity C-reactive protein (Hs-CRP) in non-communicable diseases: a review. Cureus, 14(10). https://doi.org/10.7759/cureus.30225
Bertoncini-Silva, C., Vlad, A., Ricciarelli, R., Giacomo Fassini, P., Suen, V. M. M., & Zingg, J. M. (2024). Enhancing the bioavailability and bioactivity of curcumin for disease prevention and treatment. Antioxidants, 13(3), 331. https://doi.org/10.3390/antiox13030331
Bourais, I., Elmarrkechy, S., Taha, D., Mourabit, Y., Bouyahya, A., El Yadini, M., ... & Iba, N. (2023). A review on medicinal uses, nutritional value, and antimicrobial, antioxidant, anti-inflammatory, antidiabetic, and anticancer potential related to bioactive compounds of J. regia. Food Reviews International, 39(9), 6199-6249. https://doi.org/10.1080/87559129.2022.2094401
Castillo, J., & Rodríguez, I. (2003). Biochemical changes and inflammatory response as markers for brain ischaemia: molecular markers of diagnostic utility and prognosis in human clinical practice. Cerebrovascular Diseases, 17(Suppl. 1), 7-18. https://doi.org/10.1159/000074791
Chang, Y. H. (2025). Curcumin as a potential therapeutic agent for Parkinson’s disease: a systematic review. Frontiers in Pharmacology, 16, 1593191. https://doi.org/10.3389/fphar.2025.1593191
Cuevas-Cianca, S. I., Romero-Castillo, C., Gálvez-Romero, J. L., Juárez, Z. N., & Hernández, L. R. (2023). Antioxidant and anti-inflammatory compounds from edible plants with anti-cancer activity and their potential use as drugs. Molecules, 28(3), 1488. https://doi.org/10.3390/molecules28031488
Cuevas-Cianca, S. I., Romero-Castillo, C., Gálvez-Romero, J. L., Juárez, Z. N., & Hernández, L. R. (2023). Antioxidant and anti-inflammatory compounds from edible plants with anti-cancer activity and their potential use as drugs. Molecules, 28(3), 1488. https://doi.org/10.3390/molecules28031488
Dehzad, M. J., Ghalandari, H., Nouri, M., & Askarpour, M. (2023). Antioxidant and anti-inflammatory effects of curcumin/turmeric supplementation in adults: A GRADE-assessed systematic review and dose–response meta-analysis of randomized controlled trials. Cytokine, 164, 156144. https://doi.org/10.1016/j.cyto.2023.156144
Ebrahimzadeh, A., Abbasi, F., Ebrahimzadeh, A., Jibril, A. T., & Milajerdi, A. (2021). Effects of curcumin supplementation on inflammatory biomarkers in patients with rheumatoid arthritis and ulcerative colitis: A systematic review and meta-analysis. Complementary Therapies in Medicine, 61, 102773. https://doi.org/10.1016/j.ctim.2021.102773
Ferguson, J. J., Abbott, K. A., & Garg, M. L. (2021). Anti-inflammatory effects of oral supplementation with curcumin: a systematic review and meta-analysis of randomized controlled trials. Nutrition Reviews, 79(9), 1043-1066. https://doi.org/10.1093/nutrit/nuaa114
Fokunang, C., Fokunang, E. T., Frederick, K., Ngameni, B., & Ngadjui, B. (2018). Overview of non-steroidal anti-inflammatory drugs (nsaids) in resource limited countries. Moj Toxicol, 4(1), 5-13. https://doi.org/10.15406/mojt.2018.04.00081
Goswami, S., Saxena, S., Yadav, S., Goswami, D., Brahmachari, K., Karmakar, S., ... & Brahmachari, S. (2022). Review of curcumin and its different formulations: pharmacokinetics, pharmacodynamics and pharmacokinetic-pharmacodynamic interactions. OBM Integrative and Complementary Medicine, 7(4), 1-35. http://dx.doi.org/10.21926/obm.icm.2204057
He, Y., Liu, Y., & Zhang, M. (2025). The beneficial effects of curcumin on aging and age-related diseases: From oxidative stress to antioxidant mechanisms, brain health and apoptosis. Frontiers in Aging Neuroscience, 17, 1533963. https://doi.org/10.3389/fnagi.2025.1533963
Higgins, J. P. T., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M. J., & Welch, V. A. (Eds.). (2024). Cochrane handbook for systematic reviews of interventions (Version 6.5). Cochrane. https://www.cochrane.org/handbook
Kavyani, Z., Najafi, K., Naghsh, N., Karvane, H. B., & Musazadeh, V. (2024). The effects of curcumin supplementation on biomarkers of inflammation, oxidative stress, and endothelial function: A meta-analysis of meta-analyses. Prostaglandins & Other Lipid Mediators, 174, 106867. https://doi.org/10.1016/j.prostaglandins.2024.106867
Marčetić, M., Bufan, B., Drobac, M., Antić Stanković, J., Arsenović Ranin, N., Milenković, M. T., & Božić, D. D. (2025). Multifaceted biological properties of verbascoside/acteoside: antimicrobial, cytotoxic, anti-inflammatory, and immunomodulatory effects. Antibiotics, 14(7), 697. https://doi.org/10.3390/antibiotics14070697
Menzel, A., Samouda, H., Dohet, F., Loap, S., Ellulu, M. S., & Bohn, T. (2021). Common and novel markers for measuring inflammation and oxidative stress ex vivo in research and clinical practice—which to use regarding disease outcomes?. Antioxidants, 10(3), 414. https://doi.org/10.3390/antiox10030414
Naghsh, N., Musazadeh, V., Nikpayam, O., Kavyani, Z., Moridpour, A. H., Golandam, F., Faghfouri, A. H., & Ostadrahimi, A. (2023). Profiling inflammatory biomarkers following curcumin supplementation: An umbrella meta-analysis of randomized clinical trials. Evidence-Based Complementary and Alternative Medicine, 2023, 4875636. https://doi.org/10.1155/2023/4875636.
Nie, J., Zhou, L., Tian, W., Liu, X., Yang, L., Yang, X., ... & Wei, J. (2025). Deep insight into cytokine storm: from pathogenesis to treatment. Signal Transduction and Targeted Therapy, 10(1), 112. https://doi.org/10.1038/s41392-025-02178-y
Pagano, C., Navarra, G., Coppola, L., Avilia, G., Bifulco, M., & Campiglia, P. (2021). Anti-inflammatory effects of oral supplementation with curcumin: A systematic review and meta-analysis of randomized controlled trials. Nutrition Reviews, 79(9), 1049–1064. https://doi.org/10.1093/nutrit/nuab020
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., ... Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71
Ramírez-Mendoza, A. A., Ramírez-Herrera, M. A., Cortez-Álvarez, C. R., Nery-Flores, S. D., Tejeda-Martínez, A. R., Romero-Prado, M. M. D. J., & Mendoza-Magaña, M. L. (2022). Curcumin modifies the activity of plasmatic antioxidant enzymes and the hippocampal oxidative profile in rats upon acute and chronic exposure to ozone. Molecules, 27(14), 4531. https://doi.org/10.3390/molecules27144531
Ribeiro, A. L., Barton, A., Schwenk, J. M., Bertheussen, H., de Wit, M., Goodyear, C., ... & FitzGerald, O. (2025). Molecular Biomarkers for Predicting Treatment Response in Psoriatic Arthritis. Rheumatic Disease Clinics, 51(3), e1-e15. https://doi.org/10.1016/j.rdc.2026.02.012
Sahebkar, A., Cicero, A. F. G., Simental-Mendía, L. E., Aggarwal, B. B., & Gupta, S. C. (2019). Curcumin downregulates human tumor necrosis factor-α levels: A systematic review and meta-analysis of randomized controlled trials. Pharmacological Research, 153, 104593. https://doi.org/10.1016/j.phrs.2016.03.026
Santana, P. T., de Lima, I. S., Silva e Souza, K. C. D., Barbosa, P. H. S., & de Souza, H. S. P. (2024). Persistent activation of the P2X7 receptor underlies chronic inflammation and carcinogenic changes in the intestine. International journal of molecular sciences, 25(20), 10874. https://doi.org/10.3390/ijms252010874
Sindhughosa, D. A., & Pranamartha, A. G. M. K. (2017). The involvement of proinflammatory cytokines in diabetic nephropathy: Focus on interleukin 1 (IL-1), interleukin 6 (IL-6), and tumor necrosis factor-alpha (TNF-α) signaling mechanism. Bali Med J, 6(1), 44-51. https://doi.org/10.15562/bmj.v6i1.299
Sohail, R., Mathew, M., Patel, K. K., Reddy, S. A., Haider, Z., Naria, M., ... & Patel, K. K. (2023). Effects of non-steroidal anti-inflammatory drugs (NSAIDs) and gastroprotective NSAIDs on the gastrointestinal tract: a narrative review. Cureus, 15(4). https://doi.org/10.7759/cureus.37080
Sohn, S. I., Priya, A., Balasubramaniam, B., Muthuramalingam, P., Sivasankar, C., Selvaraj, A., ... & Pandian, S. (2021). Biomedical applications and bioavailability of curcumin—An updated overview. Pharmaceutics, 13(12), 2102. https://doi.org/10.3390/pharmaceutics13122102
Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H. Y., Corbett, M. S., Eldridge, S. M., Emberson, J. R., Hernán, M. A., Hopewell, S., Hróbjartsson, A., Junqueira, D. R., Jüni, P., Kirkham, J. J., Lasserson, T., Li, T., ... Higgins, J. P. T. (2019). RoB 2: A revised tool for assessing risk of bias in randomized trials. BMJ, 366, l4898. https://doi.org/10.1136/bmj.l4898
Tagde, P., Tagde, P., Islam, F., Tagde, S., Shah, M., Hussain, Z. D., ... & Abdel-Daim, M. M. (2021). The multifaceted role of curcumin in advanced nanocurcumin form in the treatment and management of chronic disorders. Molecules, 26(23), 7109. https://doi.org/10.3390/molecules26237109
Tanin, F. A. (2024). Understanding Adverse Drug Effects and The Clinical Pharmacist's Role in Their Management. Journal of Natural Science Review, 2(4), 1-35. https://doi.org/10.62810/jnsr.v2i4.106
Teymouri, M., Mobini, M., Heshmati, J., Jafari, A., Ferns, G. A., & Rahimi, H. R. (2018). The effects of curcumin-containing supplements on biomarkers of inflammation and oxidative stress: A systematic review and meta-analysis of randomized controlled trials. Phytotherapy Research, 33(2), 253–262.
Virk, T. L., Liu, Q., Yuan, Y., Xu, X., & Chen, F. (2025). Curcumin as therapeutic modulator of impaired antioxidant defense system: implications for oxidative stress-associated reproductive dysfunction. Biology, 14(7), 750. https://doi.org/10.3390/biology14070750
Wang, Y., Ma, H., Zhang, X., Xiao, X., & Yang, Z. (2024). The increasing diagnostic role of exosomes in inflammatory diseases to leverage the therapeutic biomarkers. Journal of inflammation research, 5005-5024. https://doi.org/10.2147/jir.s475102
Yameny, A. A. (2025). IL-6, TNF-α, IL-1β, and IFN-γ cytokines as core inflammatory biomarkers: biological roles, diagnostic utility, and clinical applications. Journal of Bioscience and Applied Research, 11(3), 1055-1061. https://doi.org/10.21608/jbaar.2025.456942
Yarmohammadi, R., Najafi, K., Noroozbeygi, M., Didehvar, K., Rastin, A., Ataei, F., ... & Shushtari, S. S. (2025). The Role of IL‐6, IL‐10 and CRP in Gastrointestinal Cancers. Cell Biology International, 49(9), 1061-1078. https://doi.org/10.1002/cbin.70050
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Magenta Journal De Healthymedi
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
This journal provides direct open access to it's content on the principle that research is freely available to the public supporting a greater global exchange of knowledge. All articles published by Open Access will soon and forever be free for everyone to read and download. The license options defined for this journal are Creative Commons Attribution-ShareAlike (CC BY-SA)
